A clinical trial which is for various bacterial infections
Phase 3
Completed
- Conditions
- Health Condition 1: null- bacterial infections like Urinary Tract Infections , skin and Skin structure infections, Lower respiratory tract infection,Surgical infections
- Registration Number
- CTRI/2010/091/001046
- Lead Sponsor
- Venus Remedies Limited
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 200
Inclusion Criteria
Male and female subjects in the age group of above 18 years till 60 years shall be selected.
Presence of an abnormal chest x-ray (CXR) as determined by the primary care team in case of LRTI patients
Clinically diagnosed subjects with Respiratory tract infections mainly LRTI (Lower respiratory tract infections) , skin & skin structure infections, UTI (Urinary tract infections), surgical infections
Patients or legal guardian or LAR (Legally acceptable representative) ready to give written informed consent.
Exclusion Criteria
History of hypersensitivity reaction or any specific contraindication to Aminoglycosides or Etimicin or Amikacin
Presence of hepatic or renal disorders
History of hearing loss
Pregnant or lactating women
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To evaluate the Efficacy of Etimicin Sulphate vs Amikacin in patients suffering from various bacterial infections <br/ ><br>Timepoint: nil
- Secondary Outcome Measures
Name Time Method To evaluate the Safety and tolerability of Etimicin Sulphate vs Amikacin in patients suffering from various bacterial infections <br/ ><br>Timepoint: Nil